Investor mix
22 investors on record; lead investors include Huagai Capital, Legend Capital, Warburg Pincus.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 27% |
| Private equity | 8 | 36% |
| Bank & private debt | 1 | 5% |
| Other / undisclosed | 7 | 32% |
Developer of reformulations for cancer treatment
22 investors on record; lead investors include Huagai Capital, Legend Capital, Warburg Pincus.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 27% |
| Private equity | 8 | 36% |
| Bank & private debt | 1 | 5% |
| Other / undisclosed | 7 | 32% |